80% of people that have contracted this omnicron is fully vaccinated.

Hummmmmmm

Is it possible that vaccinated people no longer have the ability to fight this new variant, or any other variant for that matter because that experimental vaccine you agreed to take has blocked the bodies ability to fight what it has been programmed to fight?

Your body being reprogrammed has been part of this technology, and it has been explained and varified by almost every scientists, if not every scientist.

It is also common knowledge that three shots of the Phizer has no effect on this omnicron variant.

At what point will these liberal money hoarders realize this scam can not be maintained.

And how many people's lives and careers will be destroyed in the process?

And finally, when will people realize what a bunch of inept incompetent losers we have running the show.

Yes Donald...................we miss you !!!

Obsy,

All vaccines train the immune system; the covid vaccine is no different than HPV, Polio, MMR, etc.

What they are finding is that you need 3 doses of either the Phizer or Moderna vaccine to have nearly complete protection against Omicron; 1 definitely doesnt do anything and 2 could go either way.

What they are finding though is that if you only got two doses of either of those vaccines, you have a far greater chance of having only mild illness. Still, hospitalizations for covid-19 with vaccinated people is 90% lower if you are vaccinated (for the delta variant) and 80% lower chance of infection

A trio of studies in Morbidity and Mortality Weekly Report (MMWR) today show that COVID vaccines protect very well against the Delta (B1617.2) variant, with unvaccinated people having 5 times the risk of infection and more than 10 times the risk of hospitalization or death compared with vaccinated people.

COVID-19 vaccines protect against severe illness during Delta | CIDRAP (umn.edu)

As far as Omicron goes, I won't disagree with you at all that two doses seem to not be very effective against it; that's why they are recommending a third dose.

This virology stuff is quite interesting - Hopefully this IS more mild and will be the last major mutation. Time will tell obsy

The problem we have here is the other viruses you mentioned are human to human transference.

This covid is human to animal which apparently can not be cured.

This manmade virus just needs to run it's course like any other virus.

The new variants are always weaker than the original virus.

Strangely enough, I just watched a video that had Fauci stating that the vaccine has to be used on people that are not part of organized testing. THey must be regular people that can be exposed to the virus in order to accurately determine the effectiveness of it.

It was the definition of ginny pigs.

I'm so confused as to why you libs refuse to look at all the data, and all the opposing opinions. You seem to dismiss anything that differs from your views.

My .02

RESULTS

Among 1497 fully vaccinated health care workers for whom RT-PCR data were available, 39 SARS-CoV-2 breakthrough infections were documented. Neutralizing antibody titers in case patients during the peri-infection period were lower than those in matched uninfected controls (case-to-control ratio, 0.361; 95% confidence interval, 0.165 to 0.787). Higher peri-infection neutralizing antibody titers were associated with lower infectivity (higher Ct values). Most breakthrough cases were mild or asymptomatic, although 19% had persistent symptoms (>6 weeks). The B.1.1.7 (alpha) variant was found in 85% of samples tested. A total of 74% of case patients had a high viral load (Ct value, <30) at some point during their infection; however, of these patients, only 17 (59%) had a positive result on concurrent Ag-RDT. No secondary infections were documented.

CONCLUSIONS

Among fully vaccinated health care workers, the occurrence of breakthrough infections with SARS-CoV-2 was correlated with neutralizing antibody titers during the peri-infection period. Most breakthrough infections were mild or asymptomatic, although persistent symptoms did occur.

Don't let the 'perfect be the enemy of the good'. Only a fool concisously increases risk for no reward.

Yeah, you can be infected, infect other after vacination. One is likely to have less severe illness, lesser viral load and infect fewer if you're vaccinated.

Yes, 'omicron' is a mutation of earlier virus and can, like them stll infect the vaccinated. This  variety of 'Trump Flu' seems m,ore contagious but less severe than Delta, other mutations. There will be more strains in the future, this virus went from a few cases to world-wide in about a year and several mutations. 

Under Trump America became the most infected in the world and maintains that base of infection. Once it's out it's out to spread. This will be with us forever, humanity will develop resistance to existing and new mutations will enter the population from animal reservoirs (like white tail deer).

 

A health worker administering a dose of the Pfizer Covid-19 vaccine earlier this year in Jerusalem.

PHOTO: ABIR SULTAN/EPA/SHUTTERSTOCK

By Dov Lieber

 

Updated Dec. 12, 2021 2:21 pm ET

 

TEL AVIV—A booster shot of Pfizer Inc. PFE 5.14% and BioNTech SE’s BNTX 9.45% Covid-19 vaccine provides good protection against severe illness from the Omicron variant, while those without a third shot are highly vulnerable, according to a new Israeli study.

div>

The findings, similar to those announced last week by Pfizer, suggest countries worried about Omicron’s rapid spread will be able to defend their populations with continued inoculation.

Researchers at the Sheba Medical Center and from the Israeli Health Ministry examined the blood samples of 20 Sheba employees who received a booster at least a month ago, and 20 employees who are five or six months past their second shot and haven’t received a third shot.

Employees with a booster were much more likely to neutralize the Omicron variant than the two-shot group, the study showed. But the booster shots were still less effective against preventing Omicron than other variants, including Delta, still the most prevalent strain of the virus circulating globally.

 

Why Omicron’s Complex Mutations Could Change the Pandemic's Outlook

Why Omicron’s Complex Mutations Could Change the Pandemic's Outlook

Early data already suggest that the Omicron variant may be better at evading vaccine-generated antibodies, and a lot of that has to do with what’s happening at a molecular level. WSJ’s Daniela Hernandez explains.

The study’s takeaway: Individuals who received boosters may be more likely to be infected with Omicron than other variants, but they will be unlikely to develop severe illness or be hospitalized, said Gili Regev-Yochay, director of the infectious-disease epidemiology unit at Sheba Medical Center, in a news conference Saturday night.

 

The study’s bad news, said Dr. Regev-Yochay, is that people who got a “second dose of the vaccine five to six months ago don’t have any neutralizing ability.”

“If you’re past five months and didn’t get a booster, go get it,” Dr. Regev-Yochay said.

Those in the two-shot group still showed some protection against the Delta variant. The findings will soon be published in the New England Journal of Medicine. The study was based on a few dozen blood samples, Dr. Regev-Yochay said, calling it a “relatively nice size” for such a study.

Last week Pfizer said a third dose of its vaccine increased antibodies against Omicron 25-fold compared with two doses.

The studies by Israeli researchers and Pfizer, and one by scientists in South Africa, where the Omicron variant was first detected, suggest that three doses will be needed to produce the effective immune response against Omicron that was provided by just two doses against earlier virus strains.

The Israeli study’s authors said their effort was the first to combine a real sample of the Omicron variant grown in a lab with blood samples from individuals who received a booster shot. The Pfizer research was conducted on a pseudovirus meant to mimic the real one.

Pfizer and BioNTech are working on an Omicron-specific vaccine that they hope to have available by March 2022 if the variant becomes widespread by then. Researchers started working on the new vaccine on Nov. 25, shortly after Omicron was identified.